JPS6241702B2 - - Google Patents

Info

Publication number
JPS6241702B2
JPS6241702B2 JP59108268A JP10826884A JPS6241702B2 JP S6241702 B2 JPS6241702 B2 JP S6241702B2 JP 59108268 A JP59108268 A JP 59108268A JP 10826884 A JP10826884 A JP 10826884A JP S6241702 B2 JPS6241702 B2 JP S6241702B2
Authority
JP
Japan
Prior art keywords
mixture
butanol
compound
hydroxybutoxy
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP59108268A
Other languages
English (en)
Japanese (ja)
Other versions
JPS604146A (ja
Inventor
Mangishi Eruso
Sarimubeeni Arudo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ISUCHI RUSO FUARUMAKO DEITARIA SpA
Original Assignee
ISUCHI RUSO FUARUMAKO DEITARIA SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ISUCHI RUSO FUARUMAKO DEITARIA SpA filed Critical ISUCHI RUSO FUARUMAKO DEITARIA SpA
Publication of JPS604146A publication Critical patent/JPS604146A/ja
Publication of JPS6241702B2 publication Critical patent/JPS6241702B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/04—Saturated ethers
    • C07C43/13—Saturated ethers containing hydroxy or O-metal groups
    • C07C43/132—Saturated ethers containing hydroxy or O-metal groups both carbon chains being substituted by hydroxy or O-metal groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/164—Unsaturated ethers containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/178—Unsaturated ethers containing hydroxy or O-metal groups
    • C07C43/1785—Unsaturated ethers containing hydroxy or O-metal groups having more than one ether bound

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP59108268A 1983-05-30 1984-05-28 ３−（３−ヒドロキシブトキシ）−１−ブタノ−ルの分離方法 Granted JPS604146A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT21352A/83 1983-05-30
IT21352/83A IT1164254B (it) 1983-05-30 1983-05-30 3-(3-idrossibutossi)-1-butanolo e suo metodo di preparazione

Publications (2)

Publication Number Publication Date
JPS604146A JPS604146A (ja) 1985-01-10
JPS6241702B2 true JPS6241702B2 (en, 2012) 1987-09-04

Family

ID=11180528

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59108268A Granted JPS604146A (ja) 1983-05-30 1984-05-28 ３−（３−ヒドロキシブトキシ）−１−ブタノ−ルの分離方法

Country Status (8)

Country Link
US (1) US4584321A (en, 2012)
JP (1) JPS604146A (en, 2012)
BE (1) BE899790A (en, 2012)
DE (1) DE3419947A1 (en, 2012)
ES (1) ES532802A0 (en, 2012)
FR (1) FR2547813B1 (en, 2012)
GB (1) GB2142623B (en, 2012)
IT (1) IT1164254B (en, 2012)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002541129A (ja) * 1999-04-01 2002-12-03 エスペリオン セラピューティクス インコーポレイテッド エーテル化合物、組成物、およびそれらの使用
CN101426763A (zh) 2000-10-11 2009-05-06 埃斯佩里安医疗公司 用于胆固醇治疗和相关应用的硫化物和二硫化物化合物和组合物
CA2425311C (en) 2000-10-11 2011-06-14 Esperion Therapeutics, Inc. Ketone compounds and compositions for cholesterol management and related uses
US7304093B2 (en) * 2000-10-11 2007-12-04 Esperion Therapeutics, Inc. Ketone compounds and compositions for cholesterol management and related uses
EP1366024A2 (en) 2000-10-11 2003-12-03 Esperion Therapeutics Inc. Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
US20040122091A1 (en) * 2000-10-11 2004-06-24 Esperion Therapeutics, Inc. Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
MXPA03003021A (es) 2000-10-11 2003-07-14 Esperion Therapeutics Inc Compuestos de eter y composiciones para el control del colesterol y usos relacionados.
US20050020694A1 (en) * 2001-10-11 2005-01-27 Dasseux Jean-Louis Henri Sulfide and disulfide compounds and compositions for cholesterol management and related uses
US20040204502A1 (en) * 2001-10-11 2004-10-14 Dasseux Jean-Louis Henri Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
US20040192771A1 (en) * 2001-10-11 2004-09-30 Dasseux Jean-Louis Henri Ether compounds and compositions for cholesterol management and related uses
AU2003230918A1 (en) * 2002-04-10 2003-10-27 Esperion Therapeutics, Inc. Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses
MX349134B (es) 2003-01-23 2017-07-12 Esperion Therapeutics Inc Compuestos de hidroxilo y composiciones para el manejo del colesterol y usos relacionados.
CA2549995C (en) 2003-12-24 2011-11-15 Esperion Therapeutics, Inc. Ketone compounds and compositions for cholesterol management and related uses
CN103848726B (zh) * 2012-12-09 2017-09-05 河北凯盛医药科技有限公司 一种高纯度二羟二丁基醚及其制备方法
CN103304383B (zh) * 2013-06-18 2015-04-08 重庆医科大学 保胆健素的新合成方法
CN103319316B (zh) * 2013-06-24 2015-06-10 大连理工大学 一种二羟基二丁醚的绿色制备方法
CN103333057A (zh) * 2013-06-24 2013-10-02 大连理工大学 一种二羟基二丁醚的制备方法
CN104230674A (zh) * 2014-08-28 2014-12-24 成都邦泽生物医药科技有限公司 一种二羟基二丁醚的制备方法
US10912751B2 (en) 2015-03-13 2021-02-09 Esperion Therapeutics, Inc. Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease
MA41793A (fr) 2015-03-16 2018-01-23 Esperion Therapeutics Inc Associations de doses fixes comprenant du etc1002 et une ou plusieurs statines permettant de traiter ou de réduire un risque cardiovasculaire
MX2021015935A (es) 2019-06-21 2022-04-26 Esperion Therapeutics Inc Formas de sal de acido bempedoico y metodos para utilizar el mismo.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT957008B (it) * 1967-11-09 1973-10-10 Luso Farmaco Inst Processo per la preparazione di eteri simmetrici di glicoli re canti ossidrili primari e secon dari
DE2218935C3 (de) * 1972-04-19 1980-01-31 Basf Ag, 6700 Ludwigshafen Verfahren zur Herstellung von wäßrigen Lösungen von N-Vinylpyrrolidonpolymerisaten

Also Published As

Publication number Publication date
ES8507449A1 (es) 1985-10-01
ES532802A0 (es) 1985-10-01
DE3419947C2 (en, 2012) 1987-11-26
IT8321352A0 (it) 1983-05-30
DE3419947A1 (de) 1984-12-06
GB8411356D0 (en) 1984-06-06
FR2547813B1 (fr) 1989-01-27
IT1164254B (it) 1987-04-08
BE899790A (fr) 1984-11-30
JPS604146A (ja) 1985-01-10
GB2142623A (en) 1985-01-23
GB2142623B (en) 1987-04-15
IT8321352A1 (it) 1984-11-30
US4584321A (en) 1986-04-22
FR2547813A1 (fr) 1984-12-28

Similar Documents

Publication Publication Date Title
JPS6241702B2 (en, 2012)
JP4643580B2 (ja) グリオキサールジアセタールを含む粗混合物からグリオキサールジアセタールを向流液液抽出により分離する方法
JPS58105933A (ja) クロルアセトアルデヒドジメチルアセタ−ルの製法
JP2000143688A (ja) ゼアキサンチンモノ−β−グルコシドの製造方法
JPH0463875B2 (en, 2012)
CN1891680B (zh) 制备高纯度的无卤邻苯二醛的方法
JP4662686B2 (ja) Ｔｍｐ／蒸気圧濾過
CN101665427B (zh) 5-溴正戊酰溴的制法
JP4397990B2 (ja) ３−アルキルフラバノノール誘導体の精製法
JPH0273033A (ja) ４，４―ジメチル―１―（ｐ―クロロフエニル）ペンタン―３―オンの製造方法
KR101475136B1 (ko) 수용액 상에서의 2-(4-포르밀페닐)프로피온산의 친환경적인 제조방법
JP5105825B2 (ja) ４−ヒドロキシ−２−アダマンタノン化合物の製造方法
JP4081619B2 (ja) 光学活性な５−ヒドロキシ−２−デセン酸の製造方法および光学活性なマソイヤラクトンの製造方法
JP2928856B2 (ja) ビス（４―アリルオキシ―３，５―ジブロモフェニル）スルホンの製造を行う方法
SU362023A1 (ru) СПОСОБ ПОЛУЧЕНИЯ АЛКИЛОВЫХ ЭФИРОВ р-БРОМЭТИЛАЛКИЛФОСФИНОВЫХ КИСЛОТECF-ооюзнАЯ 1; nATERTviO-T?KWH4?"u4f;
TW202513046A (zh) 製備１－乙基－Ｎ－（（１，２，３，５，６，７－六氫－ｓ－二環戊二烯并苯－４－基）胺甲醯基）哌啶－４－磺醯胺之製備方法
Easson et al. 261. Molecular dissymmetry and physiological activity
JPH0584298B2 (en, 2012)
JPH0987288A (ja) １，３−ビス（３−アミノプロピル）−１，１，３，３−テトラオルガノジシロキサンの精製方法
JP2004217540A (ja) 没食子酸配糖体の製造方法
BE864336A (fr) Nouveaux derives d'anthracyclines
JPH0456822B2 (en, 2012)
Orcutt et al. The Synthesis of 1, 1, 2-Trimethyl-5, 6-methylenedioxyindane from Safrole
SE185254C1 (en, 2012)
JPS6221779B2 (en, 2012)

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term